China China New Product Thymopentin Acetate Gmp Manufacturer - GLP-1 (7-37) – JYMed factory and manufacturers

China New Product Thymopentin Acetate Gmp Manufacturer - GLP-1 (7-37) – JYMed

Short Description:

Product Detail

Product Tags

Feedback (2)

All we do is usually affiliated with our tenet " Buyer to start with, Belief to start with, devoting about the food packaging and environmental defense for Enfuvirtide Acetate Manufacturer, Aviptadil Acetate, Thymopentin Acetate Exporter, Special emphasis around the packaging of merchandise to avoid any damage during transportation,Detailed interest into the useful feedback and strategies of our esteemed shoppers.

China New Product Thymopentin Acetate Gmp Manufacturer - GLP-1 (7-37) – JYMed Detail:

Keywords

Human GLP-1 (7-37)
most affordable price
CAS# 106612-94-6

Quick Details

ProName: Human GLP-1 (7-37)
CasNo:106612-94-6
Molecular Formula: C151H228N40O47
Appearance: white powder
Application: 106612-94-6
DeliveryTime: prompt shipment
PackAge: according to customer’s requirements
Port: Shenzhen
ProductionCapacity: 2 Kilogram/Month
Purity: 98%
Storage: 2~8℃. protected from light
Transportation: by air
LimitNum: 1 Gram

Superiority

professional peptide manufacturer in china.

high quality with gmp grade

large scale with competitive price

our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.

Details

Molecular Formula：

C151H228N40O47

Relative Molecular Mass：

3355.71 g/mol

CAS-Number：

106612-94-6 (net)

Long-term Storage：

-20 ± 5°C

Synonyms：

Glucagon-Like Peptide 1 (7-37)

Sequence：

H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg

-Gly-OH acetate salt

Fields of Application：

Diabetes II - not yet an approved application

Active Substance：

GLP-1 (7-37) is an insulinotropic peptide generated from the precursor peptide GLP-1 (1-37). After ingestion of a meal,

the truncated bioactive sequences GLP-1 (7-37) and GLP-1 (7-36) amide are secreted by the L cells of the intestinal

mucosa. Administration of GLP-1 (7-37) acetate augments glucose induced insulin secretion and simultaneously inhibits glucagon

secretion and gastric emptying.

Company Profile:

company name:Shenzhen JYMed Technology Co.,Ltd.

Year Established:2009

Capital: 89.5 Million RMB

Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin

Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,…..

We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot

of ANDA peptide APIs and formulated products with CFDA and have over fourty patents approved.

Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of 30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.

With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.

Product detail pictures:

Related Product Guide:
Bachem | Lanreotide
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations | Lanreotide

We're commitment to offer you the aggressive cost ,superb products and solutions top quality, too as fast delivery for China New Product Thymopentin Acetate Gmp Manufacturer - GLP-1 (7-37) – JYMed , The product will supply to all over the world, such as: Oslo, India, Jamaica, In order to meet more market demands and long-term development, a 150, 000-square-meter new factory is under construction, which will be put into use in 2014. Then, we shall own a large capacity of producing. Of course, we will continue improving the service system to meet the requirements of customers, bringing health, happiness and beauty to everyone.

Cas 183552-38-7